Literature DB >> 11421840

Effects of hypertonic 75 mg/ml (7.5%) saline on extracellular water volume when used for preloading before spinal anaesthesia.

K Järvelä1, T Kööbi, P Kauppinen, S Kaukinen.   

Abstract

BACKGROUND: Prevention of hypotension during spinal anaesthesia is commonly achieved using fluid preloading. This may result in a substantial amount of excess free water retained in the body after spinal anaesthesia. We aimed to evaluate the effects of 7.5% hypertonic saline on extracellular water volume and haemodynamics when used for fluid preloading before spinal anaesthesia.
METHODS: This randomised double-blind study evaluated the effects of 75 mg/ml (7.5%) hypertonic saline (HS) on extracellular water volume and haematocrit in patients undergoing arthroscopy or other lower limb surgery under spinal anaesthesia. Amounts of 1.6 ml/kg of HS (20 patients) or 13 ml/kg of 9 mg/ml normal saline (20 patients) were administered for preloading before spinal anaesthesia with a 10 mg dose of 0.5% hyperbaric bupivacaine. Etilefrine was administered in order to maintain mean arterial pressure (MAP) at >or=80% of its baseline value. Whole-body impedance cardiography-derived cardiac index (CI) and extracellular water (ECW) were measured.
RESULTS: There were no significant differences in demographic data or in the number of blocked segments. ECW remained similar in both groups despite the much smaller amount of infused free water in the HS group. There were no significant differences between the groups in CI values during the study. The amount of etilefrine administered was similar in the treatment groups. Dilution of haematocrit was also similar in both groups.
CONCLUSION: Hypertonic 75 mg/ml (7.5%) saline is an alternative for preloading before spinal anaesthesia in situations where excess free water administration is not desired. It is effective in small doses of 1.6 ml/kg, which increase the extracellular water, plasma volume and cardiac output, and thus maintain haemodynamic stability during spinal anaesthesia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11421840     DOI: 10.1034/j.1399-6576.2001.045006776.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  6 in total

Review 1.  Crystalloid fluid choice in the critically ill : Current knowledge and critical appraisal.

Authors:  Carmen A Pfortmueller; Barbara Kabon; Joerg C Schefold; Edith Fleischmann
Journal:  Wien Klin Wochenschr       Date:  2018-03-02       Impact factor: 1.704

2.  Effects of 7.5% hypertonic saline on fluid balance after radical surgery for gastrointestinal carcinoma.

Authors:  Yong-Sheng Shao; Ying-Tian Zhang; Kai-Qin Peng; Zhuo-Yong Quan
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Effect of hypertonic saline on hypotension following induction of general anesthesia: A randomized controlled trial.

Authors:  Parviz Kashefi; Kamran Montazeri; Seyed Taghi Hashemi
Journal:  Adv Biomed Res       Date:  2014-09-04

4.  Hypertonic saline for fluid resuscitation after cardiac surgery (HERACLES): study protocol for a preliminary randomised controlled clinical trial.

Authors:  Carmen A Pfortmueller; Anna S Messmer; Benjamin Hess; David Reineke; Laura Jakob; Stefanie Wenger; Jan Waskowski; Patrick Zuercher; Frederik Stoehr; Gabor Erdoes; Markus M Luedi; Stephan M Jakob; Lars Englberger; Joerg C Schefold
Journal:  Trials       Date:  2019-06-14       Impact factor: 2.279

5.  Lidocaine coinfusion alleviates vascular pain induced by hypertonic saline infusion: a randomized, placebo-controlled trial.

Authors:  Zhiping Song; Shibiao Chen; Yang Zhang; Xiaoyun Shi; Na Zhao; Zhengyu Liao
Journal:  BMC Anesthesiol       Date:  2021-04-10       Impact factor: 2.217

Review 6.  Operating room use of hypertonic solutions: a clinical review.

Authors:  Gustavo Azoubel; Bartolomeu Nascimento; Mauricio Ferri; Sandro Rizoli
Journal:  Clinics (Sao Paulo)       Date:  2008-12       Impact factor: 2.365

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.